Therefore, it is possible that i) systemic phenotype might account for the enhanced tumor susceptibility scored in the OTRI animal group, or alternatively, ii) maternal OTR inhibition might increase tumor susceptibility by regulating the number and features of tumor initiating cells in the progeny. Here, OXTR is linked to neoplasm.